EcoDrugPlus

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSDORG00000005067
Gene Symbol: TGFBR1
3 Cross references
236 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSDORG00000011718
Gene Symbol: TRPA1
3 Cross references
228 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily M Member 8

Ensembl ID : ENSDORG00000001000
Gene Symbol: TRPM8
3 Cross references
158 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily V Member 1

Ensembl ID : ENSDORG00000009857
Gene Symbol: TRPV1
4 Cross references
134 Possible Orthologues:

Translocator Protein

Ensembl ID : ENSDORG00000012224
Gene Symbol: TSPO
4 Cross references
122 Possible Orthologues:

Transthyretin

Ensembl ID : ENSDORG00000012678
Gene Symbol: TTR
4 Cross references
166 Possible Orthologues:

Tubulin Alpha 1c

Ensembl ID : ENSDORG00000015065
Gene Symbol: TUBA1C
4 Cross references
182 Possible Orthologues:

Tubulin Alpha 3e

Ensembl ID : ENSDORG00000028053
Gene Symbol: TUBA3E
3 Cross references
154 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSDORG00000027321
Gene Symbol: TUBA4A
4 Cross references
225 Possible Orthologues:

Tubulin Alpha-1a Chain

Ensembl ID : ENSDORG00000006812
Gene Symbol: LOC105987533
4 Cross references
86 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSDORG00000014668
Gene Symbol: TUBB1
3 Cross references
186 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSDORG00000015304
Gene Symbol: TUBB3
3 Cross references
156 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).